Madison Jane Andrews, MD | |
800 Stanton L Young Blvd Ste 6300, Oklahoma City, OK 73104-5018 | |
(405) 271-5963 | |
Not Available |
Full Name | Madison Jane Andrews |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 6 Years |
Location | 800 Stanton L Young Blvd Ste 6300, Oklahoma City, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376036921 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0300X | Internal Medicine - Geriatric Medicine | 33923 (Oklahoma) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | (Oklahoma) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Amedisys Home Health | Oklahoma city, OK | Home health agency |
Elara Caring Xviii | Tulsa, OK | Home health agency |
Stillwater Medical Center Home Health Services | Stillwater, OK | Home health agency |
Stillwater Medical Center | Stillwater, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Stillwater Medical Center Authority | 2365353794 | 143 |
News Archive
Dr Katherine Appleton from the School of Psychology at Queen's University Belfast conducted the research on behalf of CAP.
iTech Medical, an information technology company, announced today that it has signed an exclusive, three-year manufacturing agreement with Thought Technology Ltd. of Montreal, Quebec for the Company's proprietary Muscle Pattern Recognition (MPR) technology.
Kathleen Hambleton once used to spend $100 a week on Marlboro Reds.
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead's investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.
The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.
› Verified 9 days ago
Entity Name | Stillwater Medical Center Authority |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558377135 PECOS PAC ID: 2365353794 Enrollment ID: O20040525001304 |
News Archive
Dr Katherine Appleton from the School of Psychology at Queen's University Belfast conducted the research on behalf of CAP.
iTech Medical, an information technology company, announced today that it has signed an exclusive, three-year manufacturing agreement with Thought Technology Ltd. of Montreal, Quebec for the Company's proprietary Muscle Pattern Recognition (MPR) technology.
Kathleen Hambleton once used to spend $100 a week on Marlboro Reds.
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead's investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.
The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.
› Verified 9 days ago
Entity Name | Ou Health Partners Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
Dr Katherine Appleton from the School of Psychology at Queen's University Belfast conducted the research on behalf of CAP.
iTech Medical, an information technology company, announced today that it has signed an exclusive, three-year manufacturing agreement with Thought Technology Ltd. of Montreal, Quebec for the Company's proprietary Muscle Pattern Recognition (MPR) technology.
Kathleen Hambleton once used to spend $100 a week on Marlboro Reds.
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead's investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.
The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Madison Jane Andrews, MD 1122 Ne 13th St # 1200, Oklahoma City, OK 73117-1039 Ph: (580) 504-9653 | Madison Jane Andrews, MD 800 Stanton L Young Blvd Ste 6300, Oklahoma City, OK 73104-5018 Ph: (405) 271-5963 |
News Archive
Dr Katherine Appleton from the School of Psychology at Queen's University Belfast conducted the research on behalf of CAP.
iTech Medical, an information technology company, announced today that it has signed an exclusive, three-year manufacturing agreement with Thought Technology Ltd. of Montreal, Quebec for the Company's proprietary Muscle Pattern Recognition (MPR) technology.
Kathleen Hambleton once used to spend $100 a week on Marlboro Reds.
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead's investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.
The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.
› Verified 9 days ago
Evelyn Lorents, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |